Construction of recombinant FGFR1 containing full-length gene and its potential application

被引:25
|
作者
Zhou, Yali [1 ]
Luo, Wenjuan [1 ]
Zheng, Lei [1 ]
Li, Miao [1 ]
Zhang, Yanmin [1 ]
机构
[1] Xi An Jiao Tong Univ, Sch Med, Xian 71006, Shaanxi Prov, Peoples R China
基金
中国国家自然科学基金;
关键词
Construction; FGFR1; Overexpression; Application; GROWTH-FACTOR RECEPTOR; ET-RHIZOMA-LEONTICIS; CHROMATOGRAPHIC CHARACTERISTICS; BREAST CARCINOMAS; SILICA SURFACE; CELL-CYCLE; IN-VITRO; CANCER; PROLIFERATION; EXPRESSION;
D O I
10.1016/j.plasmid.2010.04.004
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
FGFR1, one of the four fibroblast growth factor receptors, has been found to be over-expressed in many cancers. In this study, a full-length expression plasmid for FGFR1 was obtained by fragment amplification. The amplified PCR product was then digested and inserted into the pcDNA3.1(+) vector. A recombinant eukaryotic expression vector containing the complete CDS region of FGFR1 was successfully constructed. After it was transfected to Hek293 cell, the expression of the FGFR1 receptor in recombinant Hek293/FGFR1 was 18 times higher than that of Hek293 cell. The biological activities of high expression FGFR1 cell (Hek293/FGFR1) were verified by FCM, immunofluorescent, RT-PCR, western blot and cell cycle analysis. Then, Hek293/FGFR1 was used to screen taspine with cell membrane chromatography (CMC). Finally, we analyzed the effects of taspine on Hek293/FGFR1 cell and MCF-7 cell. In conclusion, Hek293/FGFR1 was successfully constructed. The results demonstrate that taspine can down-regulate phosphorylation of FGFR1 and ERK, and inhibit Hek293/FGFR1 and MCF-7 cell proliferation. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:60 / 67
页数:8
相关论文
共 50 条
  • [21] ENZYMATIC-SYNTHESIS OF FULL-LENGTH STRUCTURAL GENE OF GLOBIN CONTAINING STICKY ENDS
    FROLOVA, GI
    SKOBELEVA, NA
    PRASOLOV, VS
    KISELEV, LL
    DOKLADY AKADEMII NAUK SSSR, 1977, 235 (05): : 1211 - 1214
  • [22] Arabidopsis encyclopedia using full-length cDNAs and its application for functional genomics
    Seki, M
    Ishida, J
    Satou, M
    Sakurai, T
    Nakajima, M
    Enju, A
    Kamiya, A
    Akiyama, K
    Iida, K
    Narusaka, M
    Oono, Y
    Fujita, M
    Mizukado, S
    Nanjo, T
    Umezawa, T
    Kamei, A
    To, T
    Yamaguchi-Shinozaki, K
    Ecker, JR
    Davis, RW
    Theologis, A
    Carninci, P
    Kawai, J
    Hayashizaki, Y
    Sawasaki, T
    Kim, JM
    Hasegawa, Y
    Endo, Y
    Yokoyama, S
    Shinozaki, K
    PLANT AND CELL PHYSIOLOGY, 2003, 44 : S46 - S46
  • [23] Arabidopsis encyclopedia using full-length cDNAs and its application for functional genomics
    Seki, M
    Ishida, J
    Satou, M
    Sakurai, T
    Nakajima, M
    Enju, A
    Akiyama, K
    Iida, K
    Oono, Y
    Fujita, M
    Mizukado, S
    Kamei, A
    Narusaka, M
    Yamaguchi-Shinozaki, K
    Ecker, J
    Davis, R
    Theologis, A
    Shinozaki, K
    PLANT AND CELL PHYSIOLOGY, 2004, 45 : S38 - S38
  • [24] Arabidopsis encyclopedia using full-length CDNAs and its application for functional genomics
    Seki, M
    Narusaka, M
    Ishida, J
    Kamiya, A
    Nakajima, M
    Enju, A
    Oono, Y
    Sato, M
    Akiyama, K
    Sakurai, T
    Fujita, M
    Nanjo, T
    Yamaguchi-Shinozaki, K
    Ecker, J
    Davis, RW
    Theologis, A
    Masami, M
    Hayashizaki, Y
    Kawai, J
    Carninci, P
    Itoh, N
    Ishii, Y
    Arakawa, T
    Shibata, K
    Shinagawa, A
    Shinozaki, K
    PLANT AND CELL PHYSIOLOGY, 2002, 43 : S209 - S209
  • [25] Recombinant Full-Length Parathyroid Hormone (1–84)A Viewpoint by David A. Hanley
    David A. Hanley
    Drugs, 2006, 66 (18) : 2382 - 2382
  • [26] Bovine hexokinase type 1: Full-length cDNA sequence and characterisation of the recombinant enzyme
    Andreoni, F
    Serafini, G
    Laguardia, ME
    Magnani, M
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2005, 268 (1-2) : 9 - 18
  • [27] Cloning, Expression and Purification of Full-length Recombinant Ecarin and Comparing Its Expression and Function with Its Truncated Form
    Jafari, Zohreh
    Bandehpour, Mojgan
    Gheflat, Shivasadat
    Mohammadi, Nasrin
    Kazemi, Bahram
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (01):
  • [28] Biochemical Characterization of Full-Length Human Recombinant LRRK1 and LRRK2
    Civiero, L.
    Taymans, J. M.
    Beilina, A.
    Cookson, M. R.
    Baekelandt, V.
    Bubacco, L.
    Greggio, E.
    MOVEMENT DISORDERS, 2010, 25 : S634 - S634
  • [29] Use of full-length recombinant calflagin and its C fragment for improvement of diagnosis of Trypanosoma cruzi infection
    Marcipar, IS
    Roodveldt, C
    Corradi, G
    Cabeza, ML
    Brito, MEF
    Winter, LMF
    Marcipar, AJ
    Silber, AM
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (11) : 5498 - 5503
  • [30] Construction of a full-length iASPP expression plasmid pcDNA3.1(+)/iASPP and its biological activity
    Liu, Ze-Jun
    Gao, Xing
    Cai, Yun
    Yang, Xin
    Fu, Xiao-Lan
    Chen, Jie
    Zhang, Xiao-Bing
    Xin, Hai-Ming
    PLASMID, 2009, 62 (01) : 10 - 15